Prevalence of Helicobacter pylori infection in advanced gastric carcinoma

Arquivos de Gastroenterologia

Volumn 43, Issue 4, 2006, Pages 288-292

  Araújo Filho, Irami ^a   Brandão Neto, José ^a   Pinheiro, Laíza Araújo Mohana ^a   Azevedo, Ítalo Medeiros ^a   Freire, Flávio Henrique Miranda Araújo ^a   Medeiros, Aldo Cunha ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

^b Cidade Jardim   (Brazil)

Author keywords

Carcinoma; Helicobacter infections; Stomach neoplasms

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; OMEPRAZOLE;

ADULT; AGED; ARTICLE; CHRONIC GASTRITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GASTRECTOMY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; SEROLOGY; STOMACH CARCINOMA;

ADULT; AGED; AZURE STAINS; BIOPSY; CARCINOMA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; STOMACH; STOMACH NEOPLASMS; UREASE;

EID: 34147153277     PISSN: 00042803     EISSN: 16784219     Source Type: Journal    
DOI: 10.1590/S0004-28032006000400009     Document Type: Article

References (51)

1. Argent RH, Kidd M, Owen RJ, Thomas RJ, Limb MC, Atherton JC. Determinants and consequences of different levels of CagA phosphorylation for clinical isolates of Helicobacter pylori. Gastroenterology. 2004;127:514-23.
2. Banatvala N, Mayo K, Megraud F, Jennings R, Deeks JJ, Feldman RA. The cohort effect and Helicobacter pylori. J Infect Dis. 1993;168:219-21.
3. Blaser MJ, Chyou PH, Nomura A. Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer and duodenal ulcer risk. Cancer Res. 1995;55:562-5.
4. Blecker U, Vandenplas Y. Ethnic differences in Helicobacter pylori infection. Eur J Pediatr. 1993;152:377-80.
5. Caruso ML, Fucci L. Histological identification of Helicobacter pylori in early and advanced gastric cancer. J Clin Gastroenterol. 1990;12:601-2.
6. Citelly D, Henao S, Orozco O, Martinez J. Detección de Helicobacter pylori en Colombia: diferentes metodologias aplicadas a su studio en una población de alto riesgo de cancer gástrico. Rev Colomb Gastroenterol. 1999;14:164-9.
7. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process. First American Cancer Society Award Lecture On Cancer Epidemiology and Prevention. Cancer Res. 1992;52:6735-40.
8. Correa P. Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol. 1995;19:s37-s43.
9. Craanen ME, Blok P, Dekker W, Tytgat GN. Helicobacter pylori and early gastric cancer. Gut. 1994;35:1372-74.
10. Crabtree JE, Wyatt JI, Sobala GM, Miller G, Tompkins DS, Primrose JN, Morgan AG. Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer. Gut. 1993;34:1339-43.
11. Danesh J. Helicobacter pylori infection and gastric cancer: systematic review of the epidemiological studies. Aliment Pharmacol Ther. 1999;13:851-6.
12. The European Helicobacter pylori study group. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. Gut. 1997;41:8-13.
13. Fujioka T, Murakami K, Kodama M, Kagawa J, Okimoto T, Sato R. Helicobacter pylori and gastric carcinoma-from the view point of animal model. Keio J Med. 2002;51 Suppl 2:69-73.
14. Hansson L-E, Engstrand L, Nyrén O, Evans DJ Jr, Lindgren A, Bergstrom R Andersson B, Athlin L, Bendtsen O, Tracz P. Helicobacter pylori infection: independent risk indicator of gastric adenocarcinoma. Gastroenterology. 1993;105:1098-103.
15. Hirata Y, Yanai A, Shibata W, Mitsuno Y, Maeda S, Ogura K, Yoshida H, Kawabe T, Omata M. Functional variability of CagA gene in Japanese isolates of Helicobacter pylori. Gene. 2004;343:165-72.
16. Hiyama T, Haruma K, Kitadai Y, Masuda H, Miyamoto M, Tanaka S, Yoshihara M, Shimamoto F, Chayama K. K-ras mutation in Helicobacter pylori-associated chronic gastritis in patients with and without gastric cancer. Int J Cancer. 2002;97:562-6.
17. Huang JQ, Sridhar S, Chen Y, Hunt RH. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology. 1998;114:1169-79.
18. Huang JQ, Zheng GF, Sumanac K, Irvine EJ, Hunt RE. Meta-analysis of the relationship between cagA seropositivity and gastric cancer. Gastroenterology. 2003;125:1636-44.
19. International Agency for Research on Cancer (IARC). Schistosomes, liver flukes and Helicobacter pylori. Working Group on the Evaluation of Carcinogenic Risks to Humans. IARC Monogr Eval Carcinog Risks Hum. 1994;61:177-241.
20. Karnes WE Jr, Samlo VIM, Siurala M, Kekky M, Sipponem P, Kim SW, Walsh JH. Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterology; 1991;101:167-74.
21. Kikuchi S. Epidemiology of Helicobacter pylori and gastric cancer. Gastric Cancer. 2002;5:6-15.
22. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histoclinical classification. Acta Pathol Microbiol Scand. 1965;64:31-49.
23. Lee SG, Kim B, Yook JH, Oh ST, Lee I, Song K. TNF/LTA polymorphisms and risk for gastric cancer/duodenal ulcer in the Korean population. Cytokine. 2004;28:75-82.
24. Lu W, Pan K, Zhang L, Lin D, Miao X, You W. Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor alpha and risk of gastric cancer in a Chinese population. Carcinogenesis. 2005;26:631-6.
25. Meining A, Stolte M, Hatz R, Lehn N, Miehlke S, Morgner A, Bayerdrffer E. Differing degree and distribution of gastritis in Helicobacter pylori associated diseases. Virch Arch. 1997;431:11-5.
26. Meining A, Bayerdrffer E, Stolte M. Helicobacter pylori gastritis of the gastric cancer phenotype in relatives of gastric carcinoma patients. Eur J Gastroenterol Hepatol. 1999;11:717-20.
27. Menaker RJ, Sharaf AA, Jones NL. Helicobacter pylori infection and gastric cancer: host, bug, environment, or all three? Curr Gastroenterol Rep. 2004;6:429-35.
28. Miehlke S, Hackelsberge R, Meining A, Hatz R, Lehn N, Malfertheiner P, Stolte M, Bayerdrffer E. Severe expression of corpus gastritis is characteristic in gastric cancer patients infected with Helicobacter pylori. Br J Cancer. 1998;78:263-6.
29. Nogueira AM, Ribeiro GM, Rodrigues MA, Queiroz DM, Mendes EN, Rocha GA, Barbosa AJ. Prevalence of Helicobacter pylori in Brazilian patients with gastric carcinoma. Am J Clin Pathol. 1993;100:236-9.
30. Nomura A, Stemmermann GN, Chyou P-H, Kato I, Perez-Perez GI, Blaser MJ. Helicobacter pylori infection and gastric carcinoma among Japanese-Americans in Hawaii. N Engl J Med. 1991;325:1132-6.
31. Oliveira AG, Santos A, Guerra JB, Rocha GA, Rocha AMC, Oliveira CA, Cabral MMDA, Nogueira AMMF, Queiroz DMM. babA2- and cagA-positive Helicobacter pylori strains are associated with duodenal ulcer and gastric carcinoma in Brazil. J Clin Microbiol. 2003;41:3964-6.
32. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med. 1991;325:1127-31.
33. Parsonnet J, Vandersteen D, Goates J, Sibley RK, Pritikin J, Chang Y. Helicobacter pylori infection in intestinal- and diffuse-type gastric adenocarcinomas. J Natl Cancer Inst. 1991;83:640-3.
34. Parsonnet J, Harris RA, Hack HM, Owens DK. Modelling costeffectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials. Lancet. 1996;348:150-4.
35. Pereira LPLB, Waisberg J, André EA, Zanoto A, Mendes Jr. JP, Soares HP. Detection of Helicobacter pylori in gastric cancer. Arq Gastroenterol. 2001;38:240-6.
36. Pounder RE, Ng D. The prevalence of Helicobacter pylori infection in different countries. Aliment Pharmacol Ther. 1995;9:33-40.
37. Rad R, Dossumbekova A, Neu B, Lang R, Bauer S, Saur D, Gerhard M, Prinz C. Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host-specific colonisation during Helicobacter pylori infection. Gut. 2004;53:1082-9.
38. Rocha GA, Queiroz DMM, Mendes EN, Oliveira AM, Moura SB, Silva JR. Indirect immunofluorescence determination of the frequency of anti-H. pylori antibodies in Brazilian blood donors. Braz J Med Biol Res. 1992;25:683-9.
39. Saito K, Arai K, Mori M, Kobayashi R, Ohki I. Effect of Helicobacter pylori eradication on malignant transformation of gastric adenoma. Gastrointest Endosc. 2000;52:27-32.
40. Shimizu N, Ikehara Y, Inada K, Nakanishi H, Tsukamoto T, Nozaki K, Kaminishi M, Kuramoto S, Sugiyama A, Katsuyama T, Tatematsu M. Eradication diminishes enhancing effects of Helicobacter pylori infection on glandular stomach carcinogenesis in Mongolian gerbils. Cancer Res. 2000;60:1512-4.
41. Smoak BL, Kelley PW, Taylor DN. Seroprevalence of Helicobacter pylori infections in a cohort of US army recruits. Am J Epidemiol. 1994;139:513-9.
42. Souto FJ, Fontes CJ, Rocha GA, Oliveira AM, Mendes EN, Queiroz DM. Prevalence of Helicobacter pylori infection in a rural area of the State of Mato Grosso, Brazil. Mem Inst Oswaldo Cruz. 1998;93:171-4.
43. Tang YL, Gan RL, Dong BH, Jiang RC, Tang RJ. Detection and location of Helicobacter pylori in human gastric carcinomas. World J Gastroenterol. 2005;11:1387-91.
44. Uemura N, Mukai T, Okamoto S, Yamaguchi S, Mashiba H, Taniyama K, Sasaki N, Haruma K, Sumii K, Kajiyama G. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers Prev. 1997;6:639-42.
45. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamagushi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345:784-9.
46. Wang J, Chi DS, Kalin GB, Sosinski C, Miller LE, Burja I, Thomas E. Helicobacter pylori infection and oncogene expressions in gastric carcinoma and its precursor lesions. Dig Dis Sci. 2002;47:107-13.
47. Watanabe T, Tada M, Nagai H, Sasaki S, Nakao M. Helicobacter pylori infection induces gastric cancer in Monogolian Gerbils. Gastroenterology. 1998;115:642-8.
48. Webb PM, Forman D. Helicobacter pylori as a risk factor for cancer. Baillieres Clin Gastroenterol. 1995;9:563-82.
49. Wong BC, Lam SK, Wong WM. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA. 2004;291:187-4.
50. Yamaji Y, Mitsushima T, Ikuma H, Okamoto M, Yoshida H, Kawabe T, Shiratori Y, Saito K, Yokouchi K, Omata M. Inverse background of Helicobacter pylori antibody and pepsinogen in reflux oesophagitis compared with gastric cancer: analysis of 5732 Japanese subjects. Gut. 2001;49:335-40.
51. Yang J, Hu Z, Xu Y, Shen J, Niu J, Hu X, Guo J, Wei Q, Wang X, Shen H. Interleukin-1B gene promoter variants are associated with an increased risk of gastric cancer in a Chinese population. Cancer Lett. 2004;215:191-8.